维普中文期刊产品整合服务
786篇 您的检索式:作者名="FISHER F"
    题名 作者 年代 出处 被引量
1血管内超声去肾交感神经术治疗高血压:一项多中心,国际,单盲,随机,假手术对照试验显示文摘早期研究表明,基于射频的去肾交感神经术可降低中度高血压患者的血压。研究者研究了在没有使用抗高血压药物的情况下,使用血管内超声去。肾交感神经术是否会降低高血压患者的动态血压。刘青 叶鹏 Azizi M Schmieder RE Mahfoud F Weber MA Daemen J Davies J Basile J Kirtane AJ Wang Y Lobo MD Saxena M Feyz L Rader F Lurz P Sayer J Sapoval M Levy T Sanghvi K Abraham J Sharp ASP Fisher NDL Bloch MJ Reeve-Stoffer H Coleman L Mullin C Mauri L 2018中华高血压杂志2018,26,10:27
2Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors显示文摘AIM:To evaluate systemic treatment choices in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors(PNETs)and provide consensus treatment recommendations.METHODS:Systemic treatment options for pancreatic neuroendocrine tumors have expanded in recent years to include somatostatin analogs,angiogenesis inhibitors,inhibitors of mammalian target of rapamycinand cytotoxic agents.At this time,there is little data to guide treatment selection and sequence.We therefore assembled a panel of expert physicians to evaluate systemic treatment choices and provide consensus treatment recommendations.Treatment appropriateness ratings were collected using the RAND/UCLA modified Delphi process.After studying the literature,a multidisciplinary panel of 10 physicians assessed the appropriateness of various medical treatment scenarios on a 1-9 scale.Ratings were done both before and after an extended discussion of the evidence.Quantitative measurements of agreement were made and consensus statements developed from the second round ratings.RESULTS:Specialties represented were medical and surgical oncology,interventional radiology,and gastroenterology.Panelists had practiced for a mean of15.5 years(range:6-33).Among 202 rated scenarios,disagreement decreased from 13.2%(26 scenarios)before the face-to-face discussion of evidence to 1%(2)after.In the final ratings,46.5%(94 scenarios)were rated inappropriate,21.8%(44)were uncertain,and30.7%(62)were appropriate.Consensus statements from the scenarios included:(1)it is appropriate to use somatostatin analogs as first line therapy in patients with hormonally functional tumors and may be appropriate in patients who are asymptomatic;(2)it is appropriate to use everolimus,sunitinib,or cytotoxic chemotherapy therapy as first line therapy in patients with symptomatic or progressive tumors;and(3)beyond first line,these same agents can be used.In patients with uncontrolled secretory symptoms,octreotide LAR doses can be titrated up to 60 mg every4 wk or up to 40 mg every 3 or 4 wk.CONCLUSION:Using the Delphi process allowed physician experts to systematically obtain a consensus on the appropriateness of a variety of medical therapies in patients with PNETs.Jonathan R Strosberg George A Fisher Al B Benson Lowell B Anthony Bulent Arslan John F Gibbs Edward Greeno Renuka V Iyer Michelle K Kim William J Maples Philip A Philip Edward M Wolin Dasha Cherepanov Michael S Broder 2015World Journal of Gastroenterology2015,21,8:2
3Aggregation in Production Functions: What Applied Economists Should Know 显示文摘Felipe J Fisher F M Metroeconomica0,54,23:1
4Methane emission from rice fields as influenced by solar radiation, temperature, and straw incorporation显示文摘Sass R L Fisher F M Turner F T 1991Global Biogeochemical Cycles1991,5,4:1
5A new apple rot disease 'Bull' s eye rot'-caused by Gloeosporium Zeller & Childs显示文摘FISHER D F 1925Proceedings of Washington State Horticultural Association1925,21,:1
6Nanoscale gas flow in shale gas sediments显示文摘Javadpour F Fisher D Unsworth M 2007Journal of Canadian Petroleum Tech- nology2007,46,10:1
7Apoptirt induces apoptosis in human transformed and malignant cells but not in normal cells显示文摘Danen-van Oorschot A A Fisher D F Grimbergen J M 1997Proc Natl Acad Sci USA1997,94,11:1
8Fiber waviness in nanotubc - reinforced polymer com- posites l: modulus predictions using efective nanotube properties 显示文摘Fisher F T 2003Composites Science and Technology2003,63,11:1
9Myocardial infarction in young adult:angiographic characterization,risk factors and prognosis(Coronary artery Surgery Study Registry)显示文摘Zimmerman F H Cameron A Fisher L D 1995J Am coll cardiol1995,26,:1
10A myosin phosphatase targeting subunit isoform transition defines a smooth muscle developmental phenotypic switch显示文摘Dirksen WP Vladic F Fisher SA 2000Am J Physiol2000,278,:1
11Allelopathy: A Potential Cause pf Regeneration Failure 显示文摘Fisher R F 1980Forestry1980,78,6:1
12The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism显示文摘BURGESS T L FISHER E F ROSS S L 1995Proc Natl Acad Sci U S A1995,92,:1
13Direct observation of pol- ymer sheathing in carbon nanotube-polycarbonate composites 显示文摘Ding W Eitan A Fisher F T 2003Nano Lett2003,3,11:1
14Nanoseale gas flow in shale gas sediments显示文摘Javadpour F Fisher D Unsworth M 2007Journal of Canadian Petroleum Tech nology2007,46,10:1
15Methane emissions from rice paddies: a process study summary 显示文摘Sass R L Fisher F M Jr 1997Nutrient Cycling in Agroecosystems1997,49,13:1
16Roberts,Human cyclin E,a new cyclin that interacts with two members of the CDC2 gene family显示文摘Koff A Cross F Fisher A 0,,06:1
17Deduced protein sequence of bone small proteoglycanⅠ(biglycan) shows homology with proteoglycanⅡ(decorin) and several nonconnective tissue proteins in a variety of species显示文摘Fisher L W Term ine J D Young M F 1989J Biol Chem1989,264,8:1
18Characterization of mice deficient in aromatase (ArKO) be- cause of targeted disruption of the Cyp19 gene显示文摘Fisher C R Graves K H Parlow A F 1998PNAS1998,95,:1
19Characterization of the hypoosmotically- induced Ca2 + response in primary astrocytes 显示文摘FISHER R SCHLIESS F 1997Glia1997,20,:1
20The existence of aggregate production functions显示文摘Fisher F M 1969Econometrica1969,37,:1
返回顶部 每页显示:
共40页 首页 上一页 第1页 下一页 末页 /40 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费